Comprehensive Molecular Profiling Identifies FOXM1 As a Key Transcription Factor for Meningioma Proliferation.

Harish N Vasudevan,Steve E Braunstein,Joanna J Phillips,Melike Pekmezci,Bryan A Tomlin,Ashley Wu,Gerald F Reis,Stephen T Magill,Jie Zhang,Felix Y Feng,Theodore Nicholaides,Susan M Chang,Penny K Sneed,Michael W McDermott,Mitchel S Berger,Arie Perry,David R Raleigh

DOI: https://doi.org/10.1016/j.celrep.2018.03.013

IF: 8.8

2018-01-01

Cell Reports

Abstract:Meningioma is the most common primary intracranial tumor, but the molecular drivers of aggressive meningioma are incompletely understood. Using 280 human meningioma samples and RNA sequencing, immunohistochemistry, whole-exome sequencing, DNA methylation arrays, and targeted gene expression profiling, we comprehensively define the molecular profile of aggressive meningioma. Transcriptomic analyses identify FOXM1 as a key transcription factor for meningioma proliferation and a marker of poor clinical outcomes. Consistently, we discover genomic and epigenomic factors associated with FOXM1 activation in aggressive meningiomas. Finally, we define a FOXM1/Wnt signaling axis in meningioma that is associated with a mitotic gene expression program, poor clinical outcomes, and proliferation of primary meningioma cells. In summary, we find that multiple molecular mechanisms converge on a FOXM1/Wnt signaling axis in aggressive meningioma.